GUARDIAN ANDROID¿ APP
Report
- Report Number
- 2032227-2024-161579
- Event Type
- Malfunction
- Date Received
- May 1, 2024
- Date of Event
- April 16, 2024
- Report Date
- September 18, 2024
- Manufacturer
- MEDTRONIC MINIMED
- Product Code
- MDS
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Occupation
- 003
Narratives
"AN ATTEMPT TO REPRODUCE THE REPORTED EVENT USING GUARDIAN CONNECT - SOFTWARE VERSION 3.5.0 INSTALLED ON SAMSUNG S9+ ANDROID 10 WITH A TRANSMITTER WAS CONDUCTED AND CONFIRMED THE ISSUE WAS REPRODUCED. THE SOFTWARE DID NOT SUCCESSFULLY ADHERE TO THE SPECIFIED REQUIREMENTS AND DID NOT PERFORMED IN ACCORDANCE WITH THE EXPECTATIONS SPECIFIED IN THE SOFTWARE REQUIREMENTS SPECIFICATIONS ES10582DOC VERSION S. AFTER CONDUCTING A THOROUGH INVESTIGATION, WE HAVE FOUND THAT IF THE INSULIN DOSE ENTERED INITIALLY IS 0.8 THE REPORT SHOWS ONLY THE 0, IF THE INSULIN DOSE ENTERED IS 1.2, THE REPORT SHOWS ONLY 1.Â. THE ESF NUMBER THAT CORRESPONDS TO THE REPORTED ENHANCEMENT IS: (B)(4).. THERE ARE NOT ANY RESOLUTION STEPS, ISSUE COULD BE FIXED IN THE NEXT RELEASE. TESTING PERFORMED BY: (B)(4). INVESTIGATION PERFORMED BY:(B)(4). AFC CODE: FA21AF SOFTWARE ANOMALY (DEFECT). INVESTIGATION COMPLETION DATE: 07/JUN/24 4:42 AM. " 5080074 GUARDIAN CONNECT (STANDALONE CGM, GC). MEDTRONIC SUBMITS THIS REPORT TO COMPLY WITH FDA REGULATIONS 21 CFR PARTS 4 AND 803. MEDTRONIC HAS MADE REASONABLE EFFORTS TO PROVIDE AS MUCH RELEVANT INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE OF THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. ANY REQUIRED FIELDS THAT ARE UNPOPULATED ARE BLANK BECAUSE THE INFORMATION IS CURRENTLY UNKNOWN OR UNAVAILABLE. MEDTRONIC WILL SUBMIT A SUPPLEMENTAL REPORT IF ADDITIONAL RELEVANT INFORMATION BECOMES KNOWN.
CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. WE THEREFORE CONSIDER THIS REPORT COMPLETE TO THE BEST OF OUR KNOWLEDGE. SELECT PATIENT INFORMATION CANNOT BE PROVIDED DUE TO REGIONAL PRIVACY REGULATIONS. MEDTRONIC SUBMITS THIS REPORT TO COMPLY WITH FDA REGULATIONS 21 CFR PARTS 4 AND 803. MEDTRONIC HAS MADE REASONABLE EFFORTS TO PROVIDE AS MUCH RELEVANT INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE OF THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. ANY REQUIRED FIELDS THAT ARE UNPOPULATED ARE BLANK BECAUSE THE INFORMATION IS CURRENTLY UNKNOWN OR UNAVAILABLE. MEDTRONIC WILL SUBMIT A SUPPLEMENTAL REPORT IF ADDITIONAL RELEVANT INFORMATION BECOMES KNOWN.
IT WAS REPORTED TO MEDTRONIC MINIMED THAT THE CUSTOMER EXPERIENCED REPORT ANOMALY. THE CUSTOMER REPORTED NO ADVERSE EVENT. THE EVENT INVOLVED PRODUCT(S) MMT-8201. TROUBLESHOOTING WAS PERFORMED, UNABLE TO RESOLVE THE ISSUE AND THE ISSUE WAS ESCALATED. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. NO PRODUCT RETURN IS REQUIRED FOR MMT-8201.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 154854 | GUARDIAN ANDROID¿ APP | SENSOR, GLUCOSE, INVASIVE | MDS | MEDTRONIC MINIMED | MMT-8201 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 6 YR | Unknown |